PLoS ONE 7:e40881 Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, DeBalsi KL, Ilkayeva OR, Stevens RD, Kheterpal I, Zhang J, Covington JD, Bajpeyi S, Ravussin E, Kraus W, Koves TR, Mynatt RL (2012) Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility
If you cannot check your glucose level and are unsure whether your symptoms represent a panic attack or hypoglycaemia, it is safest to treat as hypoglycaemia first
and (3) prolonged or recurrent exposure to CDR-activating triggers for 3-6 months from the late 1 st trimester to 18-36 months of age
Metabolism of primed, constant infusions of [1,2- 13 C 2 ] glycine and [1- 13 C 1 ] phenylalanine to urinary oxalate